Digestive Disease Associates of Rockland and Gen1 Research have partnered in a study evaluating an investigational drug for treatment of liver fibrosis in adult patients who have non-alcoholic steatohepatitis (NASH). To qualify, participants must:
- Be between the ages if 18 and 75
- Have had liver biopsy or be willing to undergo a liver biopsy
Qualified participants may receive:
- Compensation for time & travel
- Study-related care at no cost
For more information, please contact our Clinical Research Coordinator, Samantha Oberdier, at (845) 367-1621 or [email protected]
